_id
6915f676bc934aba376b2415
Ticker
SEPN
Name
Septerna, Inc. Common Stock
Exchange
NASDAQ
Address
250 East Grand Avenue, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://septerna.com
Description
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Last Close
28.47
Volume
229254
Current Price
27.38
Change
-1.19
Last Updated
2026-01-06T11:00:04.922Z
Image
data:image/webp;base64,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
Ipo Date
2024-10-25T00:00:00.000Z
Market Cap
1199500672
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.984
Sentiment Sources
1
Rating
4.25
Target Price
33.1429
Strong Buy
2
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
21495000
Cost Of Revenue
-
Gross Profit
21495000
Operating Expenses
18881000
Operating Income
2614000
Interest Expense
-
Pretax Income
8173000
Net Income
8173000
Eps
0.1792242063243624
Dividends Per Share
-
Shares Outstanding
44774192
Income Tax Expense
-
EBITDA
-9485000
Operating Margin
12.160967666899278
Total Other Income Expense Net
5559000
Cash
319989000
Short Term Investments
154357000
Receivables
8645000
Inventories
-
Total Current Assets
491681000
Property Plant Equipment
26354000
Total Assets
606653000
Payables
3729000
Short Term Debt
2117000
Long Term Debt
-
Total Liabilities
217922000
Equity
388731000
Bs_currency_symbol
USD
Depreciation
400000
Change In Working Capital
170268000
Cash From Operations
168807000
Capital Expenditures
13000
Cash From Investing
-38392000
Cash From Financing
263000
Net Change In Cash
130678000
Cf_currency_symbol
USD
PE
-
PB
3.211952405699571
ROE
2.102482179193324
ROA
1.347228151842981
FCF
168794000
Fcf Percent
7.852709932542452
Piotroski FScore
4
Health Score
63
Deep Value Investing Score
7.5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
6.8
Garp Investing Score
5.5
Growth Investing Score
4.5
Momentum Investing Score
2.5
Net Net Investing Score
4.5
Quality Investing Score
6
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
21495000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
21495000
Quarters > 0 > income Statement > operating Expenses
18881000
Quarters > 0 > income Statement > operating Income
2614000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
8173000
Quarters > 0 > income Statement > net Income
8173000
Quarters > 0 > income Statement > eps
0.1792242063243624
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
45602099
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-9485000
Quarters > 0 > income Statement > operating Margin
12.160967666899278
Quarters > 0 > income Statement > total Other Income Expense Net
5559000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
319989000
Quarters > 0 > balance Sheet > short Term Investments
154357000
Quarters > 0 > balance Sheet > receivables
8645000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
491681000
Quarters > 0 > balance Sheet > property Plant Equipment
26354000
Quarters > 0 > balance Sheet > total Assets
606653000
Quarters > 0 > balance Sheet > payables
3729000
Quarters > 0 > balance Sheet > short Term Debt
2117000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
217922000
Quarters > 0 > balance Sheet > equity
388731000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
8173000
Quarters > 0 > cash Flow > depreciation
400000
Quarters > 0 > cash Flow > change In Working Capital
170268000
Quarters > 0 > cash Flow > cash From Operations
168807000
Quarters > 0 > cash Flow > capital Expenditures
13000
Quarters > 0 > cash Flow > cash From Investing
-38392000
Quarters > 0 > cash Flow > cash From Financing
263000
Quarters > 0 > cash Flow > net Change In Cash
130678000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.1792242063243624
Quarters > 0 > ratios > PB
3.211952405699571
Quarters > 0 > ratios > ROE
2.102482179193324
Quarters > 0 > ratios > ROA
1.347228151842981
Quarters > 0 > ratios > FCF
168794000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
7.852709932542452
Quarters > 0 > health Score
63
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
119000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
119000
Quarters > 1 > income Statement > operating Expenses
29097000
Quarters > 1 > income Statement > operating Income
-28978000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-24838000
Quarters > 1 > income Statement > net Income
-24838000
Quarters > 1 > income Statement > eps
-0.562388894343162
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
44165168
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-28573000
Quarters > 1 > income Statement > operating Margin
-24351.26050420168
Quarters > 1 > income Statement > total Other Income Expense Net
4140000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
189311000
Quarters > 1 > balance Sheet > short Term Investments
137250000
Quarters > 1 > balance Sheet > receivables
2566000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
334141000
Quarters > 1 > balance Sheet > property Plant Equipment
27252000
Quarters > 1 > balance Sheet > total Assets
415231000
Quarters > 1 > balance Sheet > payables
6544000
Quarters > 1 > balance Sheet > short Term Debt
2026000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
37674000
Quarters > 1 > balance Sheet > equity
377557000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-24838000
Quarters > 1 > cash Flow > depreciation
400000
Quarters > 1 > cash Flow > change In Working Capital
2784000
Quarters > 1 > cash Flow > cash From Operations
-20287000
Quarters > 1 > cash Flow > capital Expenditures
58000
Quarters > 1 > cash Flow > cash From Investing
-786000
Quarters > 1 > cash Flow > cash From Financing
339000
Quarters > 1 > cash Flow > net Change In Cash
-20734000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.562388894343162
Quarters > 1 > ratios > PB
3.2028072578180247
Quarters > 1 > ratios > ROE
-6.578609322565865
Quarters > 1 > ratios > ROA
-5.981730651131539
Quarters > 1 > ratios > FCF
-20345000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-170.96638655462183
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
219000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
219000
Quarters > 2 > income Statement > operating Expenses
26129000
Quarters > 2 > income Statement > operating Income
-25910000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-21476000
Quarters > 2 > income Statement > net Income
-21476000
Quarters > 2 > income Statement > eps
-0.4887862074710366
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
43937410
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-25513000
Quarters > 2 > income Statement > operating Margin
-11831.050228310502
Quarters > 2 > income Statement > total Other Income Expense Net
4434000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
210045000
Quarters > 2 > balance Sheet > short Term Investments
125960000
Quarters > 2 > balance Sheet > receivables
1326000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
342469000
Quarters > 2 > balance Sheet > property Plant Equipment
28127000
Quarters > 2 > balance Sheet > total Assets
434020000
Quarters > 2 > balance Sheet > payables
4349000
Quarters > 2 > balance Sheet > short Term Debt
1937000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
33754000
Quarters > 2 > balance Sheet > equity
400266000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-21476000
Quarters > 2 > cash Flow > depreciation
397000
Quarters > 2 > cash Flow > change In Working Capital
-3286000
Quarters > 2 > cash Flow > cash From Operations
-23343000
Quarters > 2 > cash Flow > capital Expenditures
382000
Quarters > 2 > cash Flow > cash From Investing
-4874000
Quarters > 2 > cash Flow > cash From Financing
66000
Quarters > 2 > cash Flow > net Change In Cash
-28151000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.4887862074710366
Quarters > 2 > ratios > PB
3.0055170456646327
Quarters > 2 > ratios > ROE
-5.365431987728161
Quarters > 2 > ratios > ROA
-4.9481590710105525
Quarters > 2 > ratios > FCF
-23725000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-108.33333333333333
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
212000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
212000
Quarters > 3 > income Statement > operating Expenses
24930000
Quarters > 3 > income Statement > operating Income
-24718000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-20828000
Quarters > 3 > income Statement > net Income
-20668000
Quarters > 3 > income Statement > eps
-0.638229922978235
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
32383314
Quarters > 3 > income Statement > income Tax Expense
-160000
Quarters > 3 > income Statement > EBITDA
-24330000
Quarters > 3 > income Statement > operating Margin
-11659.433962264151
Quarters > 3 > income Statement > total Other Income Expense Net
3890000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
238196000
Quarters > 3 > balance Sheet > short Term Investments
112727000
Quarters > 3 > balance Sheet > receivables
1124000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
356824000
Quarters > 3 > balance Sheet > property Plant Equipment
28692000
Quarters > 3 > balance Sheet > total Assets
456554000
Quarters > 3 > balance Sheet > payables
3200000
Quarters > 3 > balance Sheet > short Term Debt
1851000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
36507000
Quarters > 3 > balance Sheet > equity
420047000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-20668000
Quarters > 3 > cash Flow > depreciation
388000
Quarters > 3 > cash Flow > change In Working Capital
-1466000
Quarters > 3 > cash Flow > cash From Operations
-20958000
Quarters > 3 > cash Flow > capital Expenditures
612000
Quarters > 3 > cash Flow > cash From Investing
-133239000
Quarters > 3 > cash Flow > cash From Financing
304151000
Quarters > 3 > cash Flow > net Change In Cash
149954000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.638229922978235
Quarters > 3 > ratios > PB
2.110847446404807
Quarters > 3 > ratios > ROE
-4.920401764564442
Quarters > 3 > ratios > ROA
-4.526956285565344
Quarters > 3 > ratios > FCF
-21570000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-101.74528301886792
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1075000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
1075000
Annuals > 0 > income Statement > operating Expenses
81898000
Annuals > 0 > income Statement > operating Income
-80823000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-72296000
Annuals > 0 > income Statement > net Income
-71798000
Annuals > 0 > income Statement > eps
-7.258922252552826
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
9891000
Annuals > 0 > income Statement > income Tax Expense
-498000
Annuals > 0 > income Statement > EBITDA
-79422000
Annuals > 0 > income Statement > operating Margin
-7518.418604651162
Annuals > 0 > income Statement > total Other Income Expense Net
8527000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
238196000
Annuals > 0 > balance Sheet > short Term Investments
112727000
Annuals > 0 > balance Sheet > receivables
1124000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
356824000
Annuals > 0 > balance Sheet > property Plant Equipment
28692000
Annuals > 0 > balance Sheet > total Assets
456554000
Annuals > 0 > balance Sheet > payables
3200000
Annuals > 0 > balance Sheet > short Term Debt
1851000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
36507000
Annuals > 0 > balance Sheet > equity
420047000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-71798000
Annuals > 0 > cash Flow > depreciation
1401000
Annuals > 0 > cash Flow > change In Working Capital
248000
Annuals > 0 > cash Flow > cash From Operations
-67470000
Annuals > 0 > cash Flow > capital Expenditures
2103000
Annuals > 0 > cash Flow > cash From Investing
-160598000
Annuals > 0 > cash Flow > cash From Financing
377781000
Annuals > 0 > cash Flow > net Change In Cash
149713000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-7.258922252552826
Annuals > 0 > ratios > PB
0.6308339066818713
Annuals > 0 > ratios > ROE
-17.09284913354934
Annuals > 0 > ratios > ROA
-15.72606964345948
Annuals > 0 > ratios > FCF
-69573000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-64.71906976744187
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
151000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
151000
Annuals > 1 > income Statement > operating Expenses
-1924000
Annuals > 1 > income Statement > operating Income
2075000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
4871000
Annuals > 1 > income Statement > net Income
4180000
Annuals > 1 > income Statement > eps
0.21440559383168442
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
19495760
Annuals > 1 > income Statement > income Tax Expense
691000
Annuals > 1 > income Statement > EBITDA
-44702000
Annuals > 1 > income Statement > operating Margin
1374.1721854304635
Annuals > 1 > income Statement > total Other Income Expense Net
2796000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
88483000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
22776000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
112678000
Annuals > 1 > balance Sheet > property Plant Equipment
17187000
Annuals > 1 > balance Sheet > total Assets
130867000
Annuals > 1 > balance Sheet > payables
2637000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
169241000
Annuals > 1 > balance Sheet > equity
-38374000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
4180000
Annuals > 1 > cash Flow > depreciation
848000
Annuals > 1 > cash Flow > change In Working Capital
926000
Annuals > 1 > cash Flow > cash From Operations
-38723000
Annuals > 1 > cash Flow > capital Expenditures
2878000
Annuals > 1 > cash Flow > cash From Investing
22122000
Annuals > 1 > cash Flow > cash From Financing
74520000
Annuals > 1 > cash Flow > net Change In Cash
57919000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.21440559383168442
Annuals > 1 > ratios > PB
-13.61055429196852
Annuals > 1 > ratios > ROE
-10.892791994579664
Annuals > 1 > ratios > ROA
3.1940825418172647
Annuals > 1 > ratios > FCF
-41601000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-275.50331125827813
Annuals > 1 > health Score
32
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
27967000
Annuals > 2 > income Statement > operating Income
-27967000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-27676000
Annuals > 2 > income Statement > net Income
-27676000
Annuals > 2 > income Statement > eps
-1.4195907212645211
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19495760
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-27390000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
291000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
30607000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
0
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
31890000
Annuals > 2 > balance Sheet > property Plant Equipment
3105000
Annuals > 2 > balance Sheet > total Assets
36119000
Annuals > 2 > balance Sheet > payables
3071000
Annuals > 2 > balance Sheet > short Term Debt
710000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
80320000
Annuals > 2 > balance Sheet > equity
-44201000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-27676000
Annuals > 2 > cash Flow > depreciation
577000
Annuals > 2 > cash Flow > change In Working Capital
1746000
Annuals > 2 > cash Flow > cash From Operations
-23303000
Annuals > 2 > cash Flow > capital Expenditures
1289000
Annuals > 2 > cash Flow > cash From Investing
-1289000
Annuals > 2 > cash Flow > cash From Financing
30051000
Annuals > 2 > cash Flow > net Change In Cash
5459000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.4195907212645211
Annuals > 2 > ratios > PB
-11.816280409945476
Annuals > 2 > ratios > ROE
62.61396800977354
Annuals > 2 > ratios > ROA
-76.62449126498518
Annuals > 2 > ratios > FCF
-24592000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Valuation > metrics > PE
0.1792242063243624
Valuation > metrics > PB
3.211952405699571
Valuation > final Score
67.88047594300428
Valuation > verdict
45.6% Undervalued
Profitability > metrics > ROE
2.102482179193324
Profitability > metrics > ROA
1.662256625739046
Profitability > metrics > Net Margin
0.38022795999069553
Profitability > final Score
39
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5605984601176649
Risk > metrics > Interest Coverage
0.14803488503794315
Risk > final Score
49
Risk > verdict
High
Liquidity > metrics > Current Ratio
84.10554225111187
Liquidity > metrics > Quick Ratio
84.10554225111187
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
47.97192742181976
Prev Valuations > 1
49.94482954335367
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
29
Prev Risks > 1
34
Prev Risks > 2
32
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:33:00.821Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-10
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.18
Earnings History > 0 > eps Estimate
-0.65
Earnings History > 0 > eps Difference
0.83
Earnings History > 0 > surprise Percent
127.6923
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.56
Earnings History > 1 > eps Estimate
-0.63
Earnings History > 1 > eps Difference
0.07
Earnings History > 1 > surprise Percent
11.1111
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.49
Earnings History > 2 > eps Estimate
-0.54
Earnings History > 2 > eps Difference
0.05
Earnings History > 2 > surprise Percent
9.2593
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.64
Earnings History > 3 > eps Estimate
-0.6867
Earnings History > 3 > eps Difference
0.0467
Earnings History > 3 > surprise Percent
6.8006
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-20
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-4.62
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-28
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-12.76
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-12.76
Earnings History > 5 > surprise Percent
-
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASepterna stock price target raised to $35 from $30 at H.C. Wainwright - Investing.com Nigeria
1/20/2026
Septerna stock price target raised to $35 from $30 at H.C. Wainwright Investing.com Nigeria
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$33.1429
Analyst Picks
Strong Buy
2
Buy
1
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Septerna, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.18
EPS Estimate
-0.65
EPS Difference
0.83
Surprise Percent
127.6923%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.